Hamilton company BioVittoria says it is in discussions with potential strategic partners and private investors in both China and the US.It also expects full Food and Drug Administration (FDA) approval through the GRAS (generally recognised as safe) status
Andrea Deuchrass Thu, 28 Jan 2010
Hamilton company BioVittoria says it is in discussions with potential strategic partners and private investors in both China and the US.
It also expects full Food and Drug Administration (FDA) approval through the GRAS (generally recognised as safe) status by the end of January or February.
The
Want to read more? It's easy.
Choose your best value subscription option
Get instant access to this article now as part of our FREE two week trial.
Get two weeks free access to NBR’s Premium Online Subscription, which includes full access to all of NBR’s great content on any device.
